| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/23/2009 | US20090105454 Prophylactic/therapeutic agent for cancer |
| 04/23/2009 | US20090105453 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents |
| 04/23/2009 | US20090105170 Multiple Heat Shock Elements |
| 04/23/2009 | US20090105155 Truncated lhrh formulations |
| 04/23/2009 | US20090105150 Angiotensin derivatives |
| 04/23/2009 | US20090105149 Compounds comprising lpa |
| 04/23/2009 | US20090105146 Proteins, nucleic acids and medicaments |
| 04/23/2009 | US20090105143 Hiv fusion inhibitor peptides with improved biological properties |
| 04/23/2009 | US20090105140 Albumin Fusion Proteins |
| 04/23/2009 | US20090105139 Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease |
| 04/23/2009 | US20090105137 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2009 | US20090105136 NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea |
| 04/23/2009 | US20090105133 Gamma-Delta T Cell Receptors |
| 04/23/2009 | US20090105132 Method for Enchancing Cyclodextrin Complexation |
| 04/23/2009 | US20090105122 Selective neuropeptide y2 receptor agonists |
| 04/23/2009 | US20090105121 Insulin Derivative |
| 04/23/2009 | US20090105120 Method for preparing tryptophan rich peptides |
| 04/23/2009 | US20090105116 Polypeptide Ligands Containing Linkers |
| 04/23/2009 | US20090105090 Phage Display By Novel Filamentous Bacteriophage |
| 04/23/2009 | US20090105088 Mutant bank |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090105084 Nucleic acid molecule encoding a novel estrogen receptor beta variant |
| 04/23/2009 | US20090104712 Hepatitis b pre-s2 nucleic acid |
| 04/23/2009 | US20090104708 Human laminin receptor crystal and uses thereof |
| 04/23/2009 | US20090104703 Nucleic Acids Encoding Proteins Involved in Sensory Transduction |
| 04/23/2009 | US20090104684 Diagnosis of carcinomas |
| 04/23/2009 | US20090104664 Use of Molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 04/23/2009 | US20090104663 Novel Hydrophobin Fusion Products, Production and Use Thereof |
| 04/23/2009 | US20090104657 Lipase Production Method |
| 04/23/2009 | US20090104644 Genetically modified cyclic-nucleotide controlled ion chan |
| 04/23/2009 | US20090104631 Psca: prostate stem cell antigen and uses thereof |
| 04/23/2009 | US20090104623 Compositions for controlling hair growth |
| 04/23/2009 | US20090104622 Extracellular/Epidermal Growth Factor Like Protein |
| 04/23/2009 | US20090104619 Human G-Protein Coupled Receptors |
| 04/23/2009 | US20090104606 Late gestation lung genes, fragments and uses thereof |
| 04/23/2009 | US20090104604 Sperm-specific cation channel, catsper2, and uses therefor |
| 04/23/2009 | US20090104275 Nanoencapsulation of Proteins |
| 04/23/2009 | US20090104265 Polymorphs of N-(4-chloro-3-methyl-5-isoxazolyl) 2-[2-methyl-4,5-(methylenedioxy)phenylacetyl] thiophene-3-sulfonamide, sodium salt |
| 04/23/2009 | US20090104249 Exotoxin Inhibitory Factor |
| 04/23/2009 | US20090104233 IDENTIFICATION OF RESIDUES CRITICAL FOR THE FUNCTION OF THE VIBRIO CHOLERAE VIRULENCE REGULATOR ToxT BY SCANNING ALANINE MUTAGENESIS |
| 04/23/2009 | US20090104231 Vaccine |
| 04/23/2009 | US20090104230 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/23/2009 | US20090104229 Novel use |
| 04/23/2009 | US20090104223 Method for Obtaining Antigenic Aggregates and the Use Thereof in Formulations |
| 04/23/2009 | US20090104220 Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity |
| 04/23/2009 | US20090104219 Antigenic polypeptide SE36 of malaria plasmodium, process for purification thereof, and vaccine and diagnostic agent using the antigen |
| 04/23/2009 | US20090104218 Group B Streptococcus |
| 04/23/2009 | US20090104217 Pharmaceutical Composition Comprising An Antigen |
| 04/23/2009 | US20090104213 Vaccine for House Dust Mite Allergen Using Naked DNA |
| 04/23/2009 | US20090104210 Peptide compounds for treating obesity and insulin resistance |
| 04/23/2009 | US20090104208 House Dust Mite Allergen |
| 04/23/2009 | US20090104205 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus |
| 04/23/2009 | US20090104203 Compositions and Methods for Regulating Osteoclast Differentiation, Activation and Bone Resorption |
| 04/23/2009 | US20090104202 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104198 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 04/23/2009 | US20090104197 vWFA and/or ANT_IG Domain Containing Proteins |
| 04/23/2009 | US20090104195 Targeted ligands |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104188 Anti-hepatitis c virus antibody and uses thereof |
| 04/23/2009 | US20090104185 Methods and Compositions for Mycoplasma Toxins |
| 04/23/2009 | US20090104180 Using selectin/immunoglobulin fusion for quelling organ transplant rejection |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104177 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 04/23/2009 | US20090104152 Glycosylated interferon alpha |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | US20090101585 Chromatographic methods |
| 04/23/2009 | DE102007049830A1 Neue Proteinvarianten durch zirkulare Permutation New protein variants by circular permutation |
| 04/23/2009 | DE102007045627A1 New transglutaminase substrate is serine protease and metalloprotease inhibitor and possesses antibiotic characteristics, useful e.g. as biocide substance to inhibit the growth of fungus, virus, bacteria and as medicinal product |
| 04/23/2009 | CA2734173A1 Igm-mediated receptor clustering and cell modulation |
| 04/23/2009 | CA2703034A1 Viral modification |
| 04/23/2009 | CA2702998A1 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 04/23/2009 | CA2702982A1 Soluble gp130 muteins with improved binding activity |
| 04/23/2009 | CA2702970A1 Manufacture, compositions and uses of coagulation factor viia modulator |
| 04/23/2009 | CA2702856A1 Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| 04/23/2009 | CA2702740A1 Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
| 04/23/2009 | CA2702686A1 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 04/23/2009 | CA2702617A1 Immunotherapy regimes dependent on apoe status |
| 04/23/2009 | CA2702611A1 Immunoassays and kits for the detection of ngal |
| 04/23/2009 | CA2702592A1 Maize stress-responsive nac transcription factors and promoter and methods of use |
| 04/23/2009 | CA2702590A1 Glycosylated mammalian ngal and use thereof |
| 04/23/2009 | CA2702582A1 Feline pancreatic lipase |
| 04/23/2009 | CA2702363A1 Human factor ix variants with an extended half life |
| 04/22/2009 | EP2051077A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/22/2009 | EP2050822A1 Hepatitis C virus replicons and replicon enhanced cells |
| 04/22/2009 | EP2050818A1 Transcriptional activators with graded transactivation potential |
| 04/22/2009 | EP2050763A2 Methods and compositions for modulating vascular integrity |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050761A1 Galactosylated peptides, their preparation and use in autoimmune diseases diagnosis |
| 04/22/2009 | EP2050760A1 Soluble gp130 muteins with improved binding activity |
| 04/22/2009 | EP2050759A1 Soluble gp 130 muteins with improved binding activity |
| 04/22/2009 | EP2050464A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 04/22/2009 | EP2050461A1 Peptides based on the sequence of human lactoferrin and their use |
| 04/22/2009 | EP2050458A1 IL24 for inducing hyperproliferative or autoimmune cell death |
| 04/22/2009 | EP2050335A1 Gene disruptions, compositions and methods relating thereto |
| 04/22/2009 | EP2050332A1 Application of fluorescent protein to horticultural plant |
| 04/22/2009 | EP2050027A2 Crystal structure of p53 mutants and their use |
| 04/22/2009 | EP2049893A2 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 04/22/2009 | EP2049683A2 Diabetes test |